About us

Lentistem® Biotech is an R&D centred medical biotechnology company which design and produce therapeutic lentiviral vectors. The company has exclusive licence to multiple technologies, which are currently being used in 18 labs around the world and cited by more than 70 international publication. Our team is working in collaboration with multiple hospitals, academic labs and government agencies in Spain to create cost-effective and precise gene-based therapies. 

Location

GENYO research centre (Centro Pfizer - Universidad de Granada - Junta de Andalucía de Genómica e Investigación Oncológica) in Parque Tecnológico de Ciencias de la Salud, Granada, Spain. 

Facilities

We have state-of-art facilities for molecular analysis, cell biology, small animal research and cell-culture facilities with P2-level safety standards to produce the highest grade viral vectors​​.

Our Team

Carlos M. Molina (MBA)
​CEO

Vaibhav Bhatia (PhD)
​CSO

Julia Martinez Martinez
​CAO

.

​Scientific Advisory Board 

 Francisco Martin (PhD)
​

 Miguel G. Toscano (PhD)
​

Per Anderson (PhD)
​

Our partners

 Join us 

Are you passionate about disruptive technologies in the health sector? Do you always dream of working in a challenging environment of a tech-startup and find innovative solutions?

​If the answer is yes, contact us